What is Mediterranean Anemia (Thalassemia)? Symptoms and Treatment

Mediterranean anemia, which is also known as "thalassemia" in the medical language, is called by this name because it is mostly seen in Mediterranean countries. However, it is now possible to detect the effects of the disease not only in Mediterranean countries but also in many parts of the world.

What is Thalassemia?

Thalassemia is a kind of hereditary disease that is generally seen in races in Mediterranean countries, and is caused by the passing of the "Beta Thalassemia" gene to the child to be born from his parents. It occurs as a result of a defect in the production of hemoglobin. There are 2 parts in the red blood cells, "hem" and "globin". Globin fragment is divided into alpha and beta. The absence or insufficiency of one of these chains managed by genes leads to thalassemia.

Thalassemia with familial transmission has been seen frequently both in the world and in Turkey in recent years. However, many carriers do not feel the symptoms. If both mother and father are carriers, the risk of developing the disease can increase to 25 percent. Today, there are 1 million 300 thousand thalassemia carriers and more than 4 thousand thalassemia patients in Turkey.

What are the Symptoms of Mediterranean Anemia (Thalassemia)?

The most common Familial Mediterranean Anemia (FAA) or symptoms of thalassemia as it is called in medicine:

How is Mediterranean anemia diagnosed? The question can be answered in different ways according to the symptoms seen in the patients. Symptoms such as permanent wounds in the leg areas, a feeling of fatigue, and darkening of the skin color show the first signs of the disease. Complaints in thalassemia may differ from other symptoms of iron deficiency and vitamin deficiency anemia. Because Mediterranean anemia is a serious blood disease. Therefore, continuous blood transfusion may be required to the patient.

Thalassemia should not be confused with Familial Mediterranean Fever (FMF), another disease seen in Mediterranean regions, or FMF disease as it is called in medicine.

What are the Causes of Mediterranean Anemia?

The most common cause of thalassemia is defective hemoglobin molecules. Defective genes inherited from mother or father are usually in children. It causes Mediterranean anemia. There are 2 parts in the red blood cells, "hem" and "globin". Globin fragment is divided into alpha and beta. Thalassemia disease may occur if one of these chains managed by genes is absent or insufficient.

What are the Types of Mediterranean Anemia?

Thalassemia minor, thalassemia major and thalassemia intermedia are types of Mediterranean anemia. The type of the disease is determined as a result of various triggers in the clinical setting.
Thalassemia Minor: Mediterranean anemia carrier is seen in thalassemia minor patients. In this type of disease, also known as beta thalassemia, patients continue their daily lives easily. In other words, no symptoms of the disease are felt. There may be defective gene transfer only to unborn children. Anemia can only be learned from blood tests done before marriage. Individuals have a slight feeling of tiredness. However, this situation is not directly associated with thalassemia. Thalassemia minor tests must be done by charging the hemoglobin molecules with electricity. Otherwise, the disease may be confused with iron deficiency anemia and cause misdiagnosis.
Thalassemia Major: It is the most severe type of Mediterranean anemia. It is seen in children born as a result of defective gene transfer from carrier parents. Symptoms begin to appear when the baby is only 6 months old. Deep anemia, growth retardation and jaundice are among the main symptoms. If left untreated, it can lead to dire consequences, including heart failure and even death.
Thalassemia Intermedia: It is the intermediate form of Mediterranean anemia. That is, the symptoms are not as mild as minor, nor as severe as major. Complaints usually start from the age of 2 and continue until the end of life. Disease and carrier probability as a result of marriage in Mediterranean anemia

What is the Thalassemia Test? How is Thalassemia Diagnosed?

Thalassemia diagnosis,

Protein electrophoresis; It is a method that enables the separation of proteins in serum or urine. The abnormal protein can be seen as a characteristic band on the electrophoresis gel and can be detected by immunofixation, which indicates which immunoglobulin is abnormal. Genetic studies are performed to confirm the diagnosis of the disease in some special cases such as prenatal (prenatal) diagnosis requirement.

Mediterranean Anemia (Thalassemia) in Child

Mediterranean anemia (Thalassemia) is inherited, and hemoglobin production occurs due to the disorder. There is a defect in the genes that control the production of hemoglobin. Mediterranean anemia can also manifest itself in the form of carriage. Carriers do not show any signs of disease. If the woman and man are carriers of thalassemia and get married, the baby will be 25% likely to be sick, 25% likely to be healthy, and 50% likely to be a carrier of thalassemia. It is beneficial for couples to have a blood test for thalassemia carrier before marriage. In the blood test, it is determined that the red blood cells (erythrocytes) of thalassemia carriers are smaller than normal. The blood test is called Thalassemia Hemoglobin Electrophoresis.

When Does Thalassemia Show Symptoms?

If the child has thalassemia major, he is born with thalassemia and severe anemia is seen in the first years of life. Instead of intact hemoglobin, these children produce a different type of hemoglobin with impaired oxygen-carrying ability. As a result, there is not enough healthy hemoglobin production and anemia, growth retardation, spleen enlargement, susceptibility to infections, changes in facial bones and liver, heart and pancreatic disorders can be seen in children. Children with thalassemia major should receive regular blood and erythrocyte transfusion once a month for life. erythrocyte transfusion them cause iron accumulation in the body as a side effect. Iron accumulation accumulates in organs, especially the heart and liver, and can damage the organs. These patients are administered drugs that increase iron excretion around the age of 2-3 to reduce iron accumulation.

What are the Symptoms of Thalassemia?

The only finding in Thalassemia Minor is anemia. The patient is sluggish and tired. Thalassemia Major usually manifests itself from birth. Anemia and jaundice become evident when the baby is 4-6 months old. The hemoglobin value begins to decrease. Color fades, loss of appetite and vomiting are seen. In order to balance anemia, the bone marrow increases the production of red blood cells, and as a result of the bone marrow's hard work and expansion, changes occur in the facial bones and the appearance of the face deteriorates. Due to the accumulation of iron, enlargement may occur in organs such as the heart, liver and pancreas. Abdominal swelling develops due to enlargement of the liver and spleen. Facial bones are deformed. Forehead, cheekbones protrude, nasal root depressed, upper teeth protrude forward. The head takes the form of four corners. His stature is short.

How to Treat Mediterranean Anemia?

Different treatment methods are applied to patients according to the type of thalassemia. However, most patients need blood transfusions every 3-4 weeks. Hemoglobin values ​​should be kept above 9.5 g/dl. The main point to be considered during treatment is iron accumulation. Frequent blood transfusions can lead to iron accumulation in patients, causing cell damage in the spleen, pancreas, heart and liver organs. Therefore, a drug called desferrioxamine given by subcutaneous infusion is administered from the age of 3 to prevent iron accumulation. Continuous blood transfusion is applied to these patients who have severe anemia since childhood. In addition, folate supplements are of great importance in the treatment of the disease. In cases of thalassemia minor, the most effective solution is a bone marrow transplant. The success rate in bone marrow transplantation is generally between 58% and 91%. Sibling, parent or cord blood can be used as stem cell source. Patients with thalassemia intermedia do not usually need a blood transfusion. However, serious treatment should be started and the patient should be kept under constant follow-up.

What are the Problems That May Occur When Mediterranean Anemia Is Not Treated?

Our Advice for Patients with Mediterranean Anemia

Read: 0

yodax